-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The new crown epidemic is still spreading around the world, and many countries in the world have adopted vaccination as an effective way to prevent new crown virus infection .
Prevent infection
Self-vaccine surplus
As one of the most severely affected countries in the world, the United States is "ambitious" in promoting new crown vaccination.
Since last year, the United States has not hesitated to spend a lot of money to sign large orders, from Pfizer Pharmaceuticals, Modena and other companies to grab orders for a variety of vaccines that are still in clinical trials.
Since Johnson & Johnson’s vaccine is a single-dose form, it can be estimated that the number of vaccines currently ordered in the United States is sufficient to vaccinate 450 million people, while the US population is about 331 million.
Japan’s "Mainichi Shimbun" pointed out that the Biden administration emphasized that foreign aid will only be officially launched when a certain degree of herd immunity is achieved in the United States .
immunity
Export but control
Although a large number of vaccines are being left unused, the United States has imposed strict controls on the export of vaccines, and even moved out of the "National Defense Production Law," which was used only during wartime, to impose export controls on raw materials for vaccine production.
Mahima Datra, CEO of India Biotech E, said that American suppliers cannot execute orders from global customers due to the National Defense Production Act.
As the main manufacturer of the new crown vaccine developed by Novavax in the United States, Adal Punawara, CEO of the Serum Institute of India, also said that the inability to obtain raw materials from the United States will seriously hinder vaccine production.
World Health Organization Director-General Tan Desai recently warned that the shortage of key materials for global new crown vaccine production has not only restricted the production of new crown vaccines, but also restricted the production of conventional childhood immunization vaccines.
child
Delay in sharing vaccines
Biden said a few days ago that the United States is in discussions with several countries to determine which country can obtain the surplus vaccines in the United States, but emphasized that before providing vaccines to other countries, it must first ensure that all Americans can get the vaccine.
As close neighbors of the United States, Mexico and Canada once closed their doors when seeking to share the surplus of the new coronavirus vaccine in the United States.
Some non-governmental organizations have also criticized the United States' new crown vaccine procurement strategy, calling on the White House to clearly set the upper limit of vaccine procurement and share the vaccine with other countries.
Under the pressure of increasing criticism from the outside world, the United States finally announced on the 18th that it will provide 2.
International public opinion pointed out that, as the world's number one power, the United States has been so forward-looking and slow to act when "lending" vaccines to neighboring countries.
Leave a message here